TCL Archive In Brief: No More Shifts Planned For Treatment Programs; Groups Seek Surgeon, Radiologist Incentives August 29, 1975
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive In Congress: DOD Cancer Research Programs Increased; Senate Passes NIH Funding Bill; Porter Won’t Seek Re-election October 22, 1999
TCL Archive DRCCA Board Fails To Agree on New Guidelines For Cancer Control Core Grants, Will Try Again June 25, 1981
